Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)

NCT00049725 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00049725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00049725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
December 31, 2004
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia